The American College of Physicians (ACP) released a statement supporting an “immediate ramping up of supply for distribution of COVID-19 vaccines equitably among and within countries in need.”
All articles by Britt Gambino
In the first 30 days following an exacerbation of chronic obstructive pulmonary disease, there is an increased risk of cardiovascular adverse events.
Researchers evaluated the association between osteoporosis and vertebral fragility fractures with cardiovascular calcification in patients with chronic obstructive pulmonary disease.
Acromegaly is associated with an increased risk for mortality from vascular and respiratory disease, but not malignant disease.
In patients admitted to the hospital with COVID-19 in New York City, critical illness is common and associated with high frequency of invasive mechanical ventilation.
Air pollution may significantly contribute to the progression of atherosclerosis and increase carotid intima-media thickness.
While pediatric patients with asthma may experience cardiac symptoms, they are rarely a sign of underlying cardiac disease.
Pulmonary Hypertension Accelerated Bayer Awards, a new program launched by Bayer US, will award up to $1 million in grants to support clinical research in pulmonary hypertension.
Patients with pulmonary arterial hypertension experienced a significant improvement in World Health Organization Functional Class when transitioned from a phosphodiesterase type 5 inhibitor to riociguat.
Suppressor of tumorigenicity 2 may function as a biomarker to identify patients with pulmonary arterial hypertension with higher REVEAL risk scores.